The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

So far, 2025 has been a 50-50 year for the 5-year-old mare Randomized . Klaravich Stables' daughter of Nyquist is a multiple grade 1 winner, but she has turned in four efforts that can be categorized ...

Combined results from two large real-world trials of a high-dose influenza vaccine have found not only does the higher dose provide superior protection against influenza than the standard regimen, it ...

Already a graded stakes winner as a 3- and 4-year-old, Randomized added to her extensive résumé at 5 with an emphatic score in the July 19 $495,000 Molly Pitcher Stakes (G3) at Monmouth Park. Making ...

Patients undergoing cardiac surgery often receive red-cell transfusions, along with the associated risks and costs. Early intraoperative normovolemic hemodilution (i.e., acute normovolemic ...

The Bluetooth Special Interest Group (SIG) has announced Bluetooth Core Specification 6.1, bringing important improvements to the popular wireless communication protocol. One new feature highlighted ...

Welcome to Battle for Dream Island Again, where you need to be the last object standing to win the game! Use BFDIA codes to get exclusive skins and enough Coins to buy even more object skins. Don’t be ...

Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA ...

Innovation of the first-line strategy optimized as abemaciclib with endocrine therapy based on the ESR1mutation of ctDNA for patients with HR-positive HER2-negative advanced metastatic breast cancer ...

Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for ...

The concept of randomized generalized second-price (RGSP) auctions sent shockwaves through the PPC community after the subject took center stage at the Google antitrust trial. While some digital ...